FDA Approves Avastin for Cervical Cancer
The US Food and Drug Administration (FDA) has approved Avastin for cervical cancer. Avastin is a cancer drug manufactured by Genentech, and is used for treating various types of cancer, including, colorectal, lung, kidney, and brain cancers. Now, the FDA says, Avastin can be used in late-stage cervical cancer.
Cervical cancer is caused by the human papillomavirus (HPV) and is spread through sexual contact; over 12,000 American women are diagnosed with the disease every year.
Avastin works by cutting off blood supply to cancerous cells and preventing new cancerous cells from growing. The drug is supposed to be used in tandem with chemotherapy drugs paclitaxel and cisplatin or in combination with paclitaxel and topotecan. More….
Category: News